Description
Luciferase Stable IMR-32 Cell Line | T6100
Luciferase Stable IMR-32 cells are derived from primary stage 4 neuroblastoma with MYCN gene amplification (a characteristic of advanced neuroblastoma). These cells have applications in understanding more about local and metastatic tumor growth patterns and exploring new cancer therapeutics.
Biosafety:
II
Organism:
Human (H. sapiens)
Source Organ:
Brain
Growth Properties:
Adherent
Morphology:
Neuronal
Clones:
N/A
Passage Number:
N/A
Population Doner:
20 hours
Seeding Density:
30,000 - 40,000 cells/cm2
Markers:
Luciferase (gene insertion), PcDNA3-Luc2 vector, neomycin resistance
Applications:
For Research Use Only
Doner Gender:
N/A
Donor Ethnicity:
Not disclosed
Knockdown Method:
N/A
Induction:
N/A
Overexpression:
N/A
Freeze Thaw:
N/A
Propagation:
The base medium for this cell line is Prigrow II medium available at abm
Preservation:
1. Freeze Medium: Complete growth medium with 20% FBS and 10% DMSO.
2. Storage Temperature: Liquid nitrogen vapour phase.
Quality Control:
1) Western blot; 2) Bioluminescence; 3) Inner salt (MTS) assay
Tumorgenicn:
N/A
Shipping Conditions:
Dry Ice
Storage Contidions:
-180°C